Duke researchers are now advocating to expand public health campaigns to include the warning signs and risk factors of ...
Most people with hypertension do not have their blood pressure under control, in part because daily medications can be ...
Duke researchers have created a new antibody that helps the immune system find and attack cancer cells and virus-infected ...
Artificial intelligence (AI) could transform care for older adults and people living with dementia, but few tools have ...
Duke researchers led by Bruce Sullenger, PhD, have developed both the first fast-acting, synthetic blood thinner that’s just ...
What if a molecule made by a bacterium in the gut could help the body burn more of the fat most closely linked to metabolic disease? New research from Duke University School of Medicine points to a ...
Duke researchers are leading a phase I clinical trial to evaluate a new experimental treatment for glioblastoma, one of the most aggressive and deadly forms of brain cancer. The drug is a type of ...
The Duke Clinical Research Institute (DCRI) will lead a national consortium focused on rigorously testing agentic artificial intelligence (AI) tools designed to improve national cardiovascular health, ...
E-cigarettes are often promoted as a better way to quit smoking than nicotine patches or gum. But Duke University School of Medicine researchers say a key piece of the story is often missing: how many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results